These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33396409)

  • 1. Micelle-in-Liposomes for Sustained Delivery of Anticancer Agents That Promote Potent TRAIL-Induced Cancer Cell Apoptosis.
    Zhang Z; Patel SB; King MR
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33396409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.
    Li J; Sharkey CC; King MR
    Sci Rep; 2015 May; 5():9987. PubMed ID: 25984950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitizing cancer cells to TRAIL-induced death by micellar delivery of mitoxantrone.
    Grandhi TS; Potta T; Taylor DJ; Tian Y; Johnson RH; Meldrum DR; Rege K
    Nanomedicine (Lond); 2014; 9(12):1775-88. PubMed ID: 24195660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL.
    Skidan I; Miao B; Thekkedath RV; Dholakia P; Degterev A; Torchilin V
    Drug Deliv; 2009 Jan; 16(1):45-51. PubMed ID: 19555308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
    Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
    Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and in vitro evaluation of TRAIL-modified, cabazitaxel -loaded polymeric micelles for achieving synergistic anticancer therapy.
    Feng C; Han X; Chi L; Sun J; Gong F; Shen Y
    J Biomater Sci Polym Ed; 2018 Oct; 29(14):1729-1744. PubMed ID: 29851539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes.
    Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Jiang X
    Nanotechnology; 2011 Jul; 22(26):265105. PubMed ID: 21586819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer.
    Guo L; Fan L; Ren J; Pang Z; Ren Y; Li J; Wen Z; Qian Y; Zhang L; Ma H; Jiang X
    Int J Nanomedicine; 2012; 7():1449-60. PubMed ID: 22619505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Kim H; Jeong D; Kang HE; Lee KC; Na K
    J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
    Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
    Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-LipoTRAIL: Targeted delivery of TRAIL-functionalized liposomal nanoparticles.
    Seifert O; Pollak N; Nusser A; Steiniger F; Rüger R; Pfizenmaier K; Kontermann RE
    Bioconjug Chem; 2014 May; 25(5):879-87. PubMed ID: 24766622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
    Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
    J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperlongumine induces cell death through ROS-mediated CHOP activation and potentiates TRAIL-induced cell death in breast cancer cells.
    Jin HO; Lee YH; Park JA; Lee HN; Kim JH; Kim JY; Kim B; Hong SE; Kim HA; Kim EK; Noh WC; Kim JI; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
    J Cancer Res Clin Oncol; 2014 Dec; 140(12):2039-46. PubMed ID: 25023940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA135a-3p and death receptor 5 plays a critical role in Tanshinone I sensitized prostate cancer cells to TRAIL induced apoptosis.
    Shin EA; Sohn EJ; Won G; Choi JU; Jeong M; Kim B; Kim MJ; Kim SH
    Oncotarget; 2014 Jul; 5(14):5624-36. PubMed ID: 25015549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer.
    Hu C; Gu F; Tai Z; Yao C; Gong C; Xia Q; Gao Y; Gao S
    Oncotarget; 2016 Sep; 7(38):61832-61844. PubMed ID: 27557520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
    Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxanes Sensitize Prostate Cancer Cells to TRAIL-Induced Apoptotic Synergy via Endoplasmic Reticulum Stress.
    Grayson KA; Hope JM; Wang W; Reinhart-King CA; King MR
    Mol Cancer Ther; 2021 May; 20(5):833-845. PubMed ID: 33632873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
    Ng CP; Bonavida B
    Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein.
    Frese S; Brunner T; Gugger M; Uduehi A; Schmid RA
    J Thorac Cardiovasc Surg; 2002 Jan; 123(1):168-74. PubMed ID: 11782771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T
    Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.